According to the authors, as retatrutide moves through clinical stages for obesity, understanding its effects on the central nervous system represents an important area of ongoing research
Support hydration, fiber intake, and electrolytes
Oral metabolic franchise, a broader portfolio of oral small molecule candidates targeting metabolic disease beyond the lead GLP-1 program Recent Highlights: In May 2026, Structure reported positive end-of-Phase 2 feedback from the FDA for aleniglipron, clearing the way to begin a Phase 3 registrational program for chronic weight management in Q3 2026
Aim the needle at the vial wall so the water trickles down rather than hitting the powder directly
NAD+ research is one of the most active areas in longevity science
Strongly reducing conditions break this bond and inactivate the peptide